Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorista and Lorista H for mild to moderate arterial hypertension
2004-004933-32Phase 4Completed
- Sponsor
- Krka
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of losartan and losartan + hydrochlorothiazide in arterial hypertension (HTN) (2 arms), sponsored by Krka. Primary endpoint: Blood pressure reduction below 140/90 mmHg. Started Feb 2005; status: completed.
02
Drugs
losartanlosartan + hydrochlorothiazide
03
Conditions
arterial hypertension (HTN)
Beyond the preview
Go deeper on 2004-004933-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004933-32.